Inhibition of pituitary type 2 deiodinase by reverse triiodothyronine does not alter thyroxine-induced inhibition of thyrotropin secretion in hypothyroid rats.
OBJECTIVE
Intrapituitary triiodothyronine (T3) production plays a pivotal role in the control of TSH secretion. Its production is increased in the presence of decreased serum thyroxine (T4) concentrations and the enzyme responsible, deiodinase type 2 (D2), is highest in hypothyroidism. In order to document the role of this enzyme in adult rats we developed an experimental model that inhibited this enzyme using the specific inhibitor, reverse T3 (rT3).


METHODS
Hypothyroidism was induced with propylthiouracil (PTU; 0.025 g/l in drinking water) which in addition blocked deiodinase type 1 (D1) activity, responsible for the rapid clearance of rT3 in vivo. During the last 7 days of the experiment, the hypothyroid rats were injected (s.c.) for 4 days with 0.4 or 0.8 nmol T4 per 100 g body weight (bw) per day. For the last 3 days, the same amount of T4 was infused via s.c. minipumps. In additional groups, 25 nmol rT3/100 g bw per day were added to the 3-day infusion of T4.


RESULTS
Infusion of 0.4 nmol T4/100 g bw per day did not affect the high serum TSH levels, 0.8 nmol T4/100 g bw per day decreased them to 57% of the hypothyroid values. The infusions of rT3 inhibited D2 activity in all organs where it was measured: the pituitary, brain cortex and brown adipose tissue (BAT). In the pituitary, the activity was 27%, to less than 15% of the activity in hypothyroidism. Despite that, serum TSH levels did not increase, serum T4 concentrations did not change and the changes in serum T3 were minimal.


CONCLUSIONS
We conclude that in partly hypothyroid rats, a 3-day inhibition of D2 activity, without concomitant change in serum T4 and minimal changes in serum T3 levels, is not able to upregulate TSH secretion and we postulate that this may be a reflection of absent or only minimal changes in circulating T3 concentrations.
Cettour-Rose
P
P
Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, University Medical Center, Faculty of Medicine, University of Geneva, 1211 Geneva 4, Switzerland.
Visser
T J
TJ
Burger
A G
AG
Rohner-Jeanrenaud
F
F
D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D007037:Hypothyroidism / Q000097:blood / Q000201:enzymology*; D007453:Iodide Peroxidase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D011441:Propylthiouracil; D051381:Rats; D017208:Rats, Wistar; D013972:Thyrotropin / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D013974:Thyroxine / Q000097:blood / Q000378:metabolism*; D014285:Triiodothyronine, Reverse / Q000494:pharmacology*
D004791:Enzyme Inhibitors; D014285:Triiodothyronine, Reverse; D011441:Propylthiouracil; D013972:Thyrotropin; D007453:Iodide Peroxidase; D013974:Thyroxine